Ramorelix
Ramorelix is a luteinizing-hormone-releasing hormone (LHRH) antagonist. Ramorelix can inhibit tumor progression in vivo. Ramorelix can be studied in anti-cancer research.
For research use only. We do not sell to patients.
- CAS No.: 127932-90-5
- Formula: C74H95ClN16O18
- Molecular Weight:1532.10
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
Chemical Information
-
CAS No. 127932-90-5
-
Molecular Weight 1532.10
-
Formula C74H95ClN16O18
-
Sequence
{d-Ala(N-acetyl-3-(2-naphthalenyl))}-{d-Phe(Cl)}-{d-Trp}-Ser-Tyr-{d-Ser(2-(aminocarbonyl)hydrazide)}-Leu-Arg-Pro
-
Sequence Shortening
{d-Ala(N-acetyl-3-(2-naphthalenyl))}-{d-Phe(Cl)}-{d-Trp}-SY-{d-Ser(2-(aminocarbonyl)hydrazide)}-LRP
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Stoeckemann, K., & Sandow, J. (1993). Effects of the luteinizing-hormone-releasing hormone (LHRH) antagonist ramorelix (hoe013) and the LHRH agonist buserelin on dimethylbenz[]anthracene-induced mammary carcinoma: studies with slow-release formulations. Journal of cancer research and clinical oncology, 119(8), 457-462. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Ramorelix Related Classifications
HY-P2115 Related Classifications
Powered by Bioz